Immunodeficient mice transplanted with human hematopoietic stem cells (HSCs) have been referred to as “Human Immune System” (HIS) mice and are a translational platform for studying human immune responses in vivo. Human HSC sources used in generating HIS mice include fetal liver (FL), umbilical cord blood (CB), and adult bone marrow (BM). Since HSCs from FL, CB, and BM are produced at various stages of human development, we tested whether mice transplanted with these three HSCs differ in their immune responses. We found that compared with CB HSCs or FL HSCs, adult BM HSCs reconstitute the immune system poorly. The resulting HIS mice do not mount an antibody response to Borrelia hermsii infection and as a consequence suffer persistently high levels of bacteremia. While both CB and FL HSCs yield comparable levels of immune reconstitution of HIS mice resulting in robust anti-B. hermsii immune responses, FL HSC-transplanted mice exhibited a discernable difference in their human B cell maturity as identified by an increased frequency of CD10+ immature B cells and relatively smaller lymphoid follicles compared with CB HSC-transplanted mice. Although CB HSC-transplanted mice generated robust antibody responses to B. hermsii and specific protein antigens of B. hermsii, they failed to respond to Salmonella typhi Vi polysaccharide, a classical T cell-independent antigen. This situation resembles that seen in human infants and young children. Therefore, CB HSC-transplanted mice may serve as a translation platform to explore approaches to overcome the impaired antipolysaccharide responses characteristic of human infants.
Get full access to this article
View all access options for this article.
References
1.
SitnickaE, BrakebuschC, MartenssonIL, SvenssonM, AgaceWW, SigvardssonM, Buza-VidasN, BryderD, CilioCM, et al. (2003). Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J Exp Med, 198:1495–1506.
2.
MartinF and KearneyJF. (2001). B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol, 13:195–201.
3.
AlugupalliKR. (2008). A distinct role for B1b lymphocytes in T cell-independent immunity. Curr Top Microbiol Immunol, 319:105–130.
4.
KantorAB, StallAM, AdamsS, HerzenbergLA and HerzenbergLA. (1992). Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci U S A, 89:3320–3324.
5.
TungJW, MrazekMD, YangY, HerzenbergLA and HerzenbergLA. (2006). Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci U S A, 103:6293–6298.
6.
StallAM, AdamsS, HerzenbergLA and KantorAB. (1992). Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann N Y Acad Sci, 651:33–43.
7.
KantorAB, StallAM, AdamsS, WatanabeK and HerzenbergLA. (1995). De novo development and self-replenishment of B cells. Int Immunol, 7:55–68.
8.
MartinF and KearneyJF. (2000). B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”. Immunol Rev, 175:70–79.
9.
BrehmMA, ShultzLD and GreinerDL. (2010). Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes, 17:120–125.
10.
ShultzLD, IshikawaF and GreinerDL. (2007). Humanized mice in translational biomedical research. Nat Rev Immunol, 7:118–130.
11.
PearsonT, GreinerDL and ShultzLD. (2008). Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol, 324:25–51.
12.
JonesC, DartonTC and PollardAJ. (2014). Why the development of effective typhoid control measures requires the use of human challenge studies. Front Microbiol, 5:707.
13.
WaddingtonCS, DartonTC, WoodwardWE, AngusB, LevineMM and PollardAJ. (2014). Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies. J Infect, 68:405–418.
14.
LibbySJ, BrehmMA, GreinerDL, ShultzLD, McClellandM, SmithKD, CooksonBT, KarlinseyJE, KinkelTL, et al. (2010). Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A, 107:15589–15594.
15.
SongJ, WillingerT, RongvauxA, EynonEE, StevensS, ManzMG, FlavellRA and GalanJE. (2010). A mouse model for the human pathogen Salmonella Typhi. Cell Host Microbe, 8:369–376.
16.
Firoz MianM, PekEA, ChenowethMJ and AshkarAA. (2011). Humanized mice are susceptible to Salmonella Typhi infection. Cell Mol Immunol, 8:83–87.
17.
MianMF, PekEA, ChenowethMJ, CoombesBK and AshkarAA. (2011). Humanized mice for Salmonella Typhi infection: new tools for an old problem. Virulence, 2:248–252.
18.
VuyyuruR, LiuH, ManserT and AlugupalliKR. (2011). Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever. Proc Natl Acad Sci U S A, 108:20707–20712.
19.
ColomboMJ and AlugupalliKR. (2008). Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes. J Immunol, 180:4858–4864.
20.
HovisKM, SchrieferME, BahlaniS and MarconiRT. (2006). Immunological and molecular analyses of the Borrelia hermsii factor H and factor H-like protein 1 binding protein, FhbA: demonstration of its utility as a diagnostic marker and epidemiological tool for tick-borne relapsing fever. Infect Immun, 74:4519–4529.
21.
AlugupalliKR, LeongJM, WoodlandRT, MuramatsuM, HonjoT and GersteinRM. (2004). B1b Lymphocytes confer T cell-independent long-lasting immunity. Immunity, 21:379–390.
22.
ManesiaJK, XuZ, BroekaertD, BoonR, van VlietA, EelenG, VanweldenT, StegenS, Van GastelN, et al. (2015). Highly proliferative primitive fetal liver hematopoietic stem cells are fueled by oxidative metabolic pathways. Stem Cell Res, 15:715–721.
23.
GriffinDO, HolodickNE and RothsteinTL. (2011). Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med, 208:67–80.
24.
HayakawaK, HardyRR, HerzenbergLA and HerzenbergLA. (1985). Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med, 161:1554–1568.
25.
JensenCT, KharaziS, BoiersC, ChengM, LubkingA, SitnickaE and JacobsenSE. (2008). FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis. Blood, 112:2297–2304.
26.
ShrinerAK, LiuH, SunG, GuimondM and AlugupalliKR. (2010). IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae. J Immunol, 185:525–531.
27.
AlugupalliKR, GersteinRM, ChenJ, Szomolanyi-TsudaE, WoodlandRT and LeongJM. (2003). The resolution of relapsing fever Borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol, 170:3819–3827.
28.
MackayF and SchneiderP. (2009). Cracking the BAFF code. Nat Rev Immunol, 9:491–502.
29.
TremlJF, HaoY, StadanlickJE and CancroMP. (2009). The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys, 53:1–16.
30.
SchmidtMR, AppelMC, GiassiLJ, GreinerDL, ShultzLD and WoodlandRT. (2008). Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One, 3:e3192.
31.
MackayF and SchneiderP. (2008). TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev, 19:263–276.
ColombettiS, LevyF and ChapatteL. (2009). IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector. Blood, 113:6629–6637.
34.
HaoZ and RajewskyK. (2001). Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med, 194:1151–1164.
35.
von Freeden-JeffryU, VieiraP, LucianLA, McNeilT, BurdachSE and MurrayR. (1995). Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med, 181:1519–1526.
36.
CarvalhoTL, Mota-SantosT, CumanoA, DemengeotJ and VieiraP. (2001). Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7-/- mice. J Exp Med, 194:1141–1150.
37.
ScholzJL, CrowleyJE, TomaykoMM, SteinelN, O'NeillPJ, QuinnWJ3rd, GoenkaR, MillerJP, ChoYH, et al. (2008). BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A, 105:15517–15522.
38.
LangJ, KellyM, FreedBM, McCarterMD, KedlRM, TorresRM and PelandaR. (2013). Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J Immunol, 190:2090–2101.
